<DOC>
	<DOCNO>NCT00323635</DOCNO>
	<brief_summary>This study do compare frequency urination night woman take tolterodine tablet vs. take placebo tablet . We also measure whether two treatment condition difference woman 's sleep , mood performance cognitive test .</brief_summary>
	<brief_title>A Comparison Tolterodine Placebo Treatments Nocturnal Frequency Sleep Quality Women After Menopause .</brief_title>
	<detailed_description>From midlife onwards , half woman complain poor sleep quality . One possible reason might increase frequency need urinate night . Women feel frequent urge urinate structure support bladder become lax . Tolterodine drug raise threshold volume urine accumulate bladder urge urinate arises . Many factor determine people say sleep , sleep record sleep-measuring instrument , closely notice night 's sleep , whether generally prone make positive negative judgment lot body symptom . In study , woman age 45 65 past menopause frequently bother need urinate night take either tolterodine placebo tablet 8 week . During last week record hour sleep quality sleep morning . They wear device wrist week continuously record whether asleep awake . During three night week record volume urine whenever urinate . At end week complete questionnaires mood take computerized test measure alertness . Thereafter repeat procedure , take kind tablet take first 8-week treatment period . We compare frequency urination , sleep , mood adjusted tendency make positive negative judgment daytime attention level find differ two treatment period , explain difference difference may find .</detailed_description>
	<mesh_term>Urinary Incontinence</mesh_term>
	<mesh_term>Enuresis</mesh_term>
	<mesh_term>Tolterodine Tartrate</mesh_term>
	<criteria>1 . Postmenopausal woman , age 45 65 year old . 2 . No menses least 6 month study start . 3 . Have least 14 episode nocturia per week . 4 . Have least 4 hot flash daily . 5 . Overall good health , evidence letter primary care provider . 6 . Agree use exogenous hormone include soy isoflavones soybeanbased shake , nutritional supplement potentially reduce hot flash . 7 . Have discontinue hormone treatment , systemic , topical , vaginal , least 60 day admission throughout participation study . 1 . Use anticholinergic , hypnotic sedating drug 2 . Presence urinary retention , gastric retention , chronic severe constipation , narrowangled glaucoma . 3 . A urinary tract infection within month study start . 4 . Undiagnosed abnormal vaginal bleeding . 5 . Benign malignant liver disease . 6 . History presence chronic alcoholism medication addiction within past 5 yr . 7 . An acute systemic infection within seven day study start . 8 . Concurrent participation another clinical trial and/or receive experimental medication/device last 30 day admission study . 9 . History shift work within past 6 month .</criteria>
	<gender>Female</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>December 2014</verification_date>
	<keyword>nocturia</keyword>
	<keyword>urinary incontinence</keyword>
	<keyword>overactive bladder</keyword>
	<keyword>tolterodine</keyword>
	<keyword>sleep</keyword>
	<keyword>sleep disorder</keyword>
	<keyword>menopause</keyword>
	<keyword>midlife woman</keyword>
	<keyword>psychological test</keyword>
</DOC>